Negative Pressure Wound Therapy Market
Number of pages: 100 | Report Format: PDF | Published date: July 14, 2022
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 2.65 billion |
|
Revenue Forecast in 2031 |
US$ 4.55 billion |
|
CAGR |
6.2% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2022-2030 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Wound Type, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global negative pressure wound therapy market was valued at US$ 2.65 billion in 2022 and is expected to register a revenue CAGR of 6.2% to reach US$ 4.55 billion by 2031.
Negative Pressure Wound Therapy Market Fundamentals
Negative pressure wound therapy is a medical treatment technique that involves the application of negative pressure to a wound site to promote wound healing. It is also known as vacuum-assisted closure (VAC) therapy. Negative pressure wound therapy utilizes a specialized device that applies controlled suction or sub-atmospheric pressure to the wound bed through a sealed dressing system. Negative pressure wound therapy promotes granulation tissue formation, which is essential for wound healing. It helps in wound contraction, the growth of new blood vessels, and the removal of non-viable tissue. The negative pressure helps to remove bacteria, biofilms, and debris from the wound, reducing the risk of infection. Negative Pressure Wound Therapy is commonly used to manage complex, chronic, or non-healing wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. It is usually applied for several days or weeks, depending on the individual wound characteristics and the healthcare provider's recommendation.
Negative Pressure Wound Therapy Market Dynamics
The increasing incidence of chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is a major driver for the negative pressure wound therapy market. With a growing aging population and higher prevalence of conditions such as diabetes and obesity, there is a rising demand for efficient wound management solutions, including negative pressure wound therapy. According to the National Center For Biotechnology Information, venous leg ulcer prevalence is between 1.5% and 3% in the general population, and about 75% of leg ulcers have venous etiology. There is an increasing awareness and acceptance of negative pressure wound therapy among healthcare professionals and patients. Negative pressure wound therapy has demonstrated its efficacy in promoting wound healing, reducing complications, and improving patient outcomes. As a result, healthcare providers are more likely to adopt negative pressure wound therapy as a standard treatment option for complex wounds. Ongoing technological advancements in negative pressure wound therapy devices, dressings, and accessories contribute to negative pressure wound therapy market growth. These advancements include the development of portable and user-friendly devices, improved dressing materials with enhanced properties, and innovations in wound monitoring and feedback systems. Healthcare systems and providers increasingly focus on achieving cost-effective care and better patient outcomes. Negative pressure wound therapy has been shown to reduce hospital stays, minimize the need for extensive wound care, and improve healing outcomes. There is a growing emphasis on patient-centric approaches in wound care, including negative pressure wound therapy. Healthcare providers recognize the importance of patient preferences, comfort, and adherence to treatment regimens. This negative pressure wound therapy industrytrend has led to the development of negative pressure wound therapy devices and dressings that are more comfortable, flexible, and patient-friendly, improving overall patient experience and outcomes.
However, negative pressure wound therapy can involve significant costs associated with the purchase or rental of devices, dressings, and ongoing supplies. Additionally, the need for skilled healthcare professionals to manage and monitor negative pressure wound therapy can add to the overall expenses, restricting the growth of negative pressure wound therapy. Negative pressure wound therapy may not suit all patients or wound types. Factors such as wound location, wound characteristics, and patient factors influence the feasibility and effectiveness of negative pressure wound therapy. Additionally, patient compliance and adherence to negative pressure wound therapy protocols, including dressing changes and device usage, are also hindering the growth of the negative pressure wound therapy market.
Negative Pressure Wound Therapy Market Ecosystem
The global negative pressure wound therapy market is analyzed from four perspectives: product, wound type, end user, and region.
Negative Pressure Wound Therapy Market by Product
Based on the product, the global negative pressure wound therapy market is segmented into conventional products and disposable products.
The conventional products segment accounted for the largest revenue share of the negative pressure wound therapy market, with 80% of the market share. Conventional negative pressure wound therapy products, such as traditional negative pressure wound therapy devices and dressings, have been used for a longer period and have gained wide acceptance in the healthcare industry. They have a well-established market presence and are familiar to healthcare providers, making them the go-to choice for many clinicians. Conventional negative pressure wound therapy products are often perceived as more cost-effective than advanced or disposable negative pressure wound therapy systems. These products are generally more affordable and accessible, making them a preferred choice, particularly in healthcare systems with budget constraints or limited reimbursement coverage. Healthcare professionals have gained significant experience and expertise in using conventional negative pressure wound therapy products over the years. They are familiar with the application techniques, device operation, and dressing changes associated with conventional negative pressure wound therapy. Conventional negative pressure wound therapy products offer a certain level of customizability and flexibility in terms of dress selection and application techniques. This allows healthcare professionals to tailor the treatment to the specific needs of individual patients and wound characteristics, enhancing treatment outcomes.
Negative Pressure Wound Therapy Market by Wound Type
Based on the wound type, the global negative pressure wound therapy market is segmented into diabetic foot ulcers, venous leg ulcers, pressure ulcers, and others.
The pressure ulcers segment accounted for a significant negative pressure wound therapy market share in 2022, with a 30.3% market share. Pressure ulcers, also known as bedsores or pressure sores, are a common healthcare challenge, particularly among individuals who are immobile or have limited mobility. The high prevalence of pressure ulcers creates a significant demand for effective wound management solutions, including negative pressure wound therapy. According to the National Center For Biotechnology Information, the global prevalence of pressure ulcers is 12.8%, with a hospital-acquired pressure injury (HAPI) incidence of 8.4%. Pressure ulcers can lead to severe complications, including infection, tissue damage, pain, and delayed wound healing. Healthcare providers recognize the importance of early intervention and optimal wound care to prevent the progression of pressure ulcers. Negative pressure wound therapy has shown efficacy in managing pressure ulcers and promoting wound healing, making it a preferred choice in treating these wounds. There is a substantial body of clinical evidence supporting the use of negative pressure wound therapy in pressure ulcer management. Clinical trials, research studies, and guidelines from professional organizations consistently highlight the benefits of negative pressure wound therapy in promoting healing and reducing complications associated with pressure ulcers.
Negative Pressure Wound Therapy Market by End User
Based on the end users, the global negative pressure wound therapy market is segmented into hospitals, ambulatory surgical centers, home care settings, and others.
The hospitals segment accounted for the highest revenue share of the negative pressure wound therapy market, with a 51% market share. Hospitals typically have advanced infrastructure and resources, including specialized wound care departments, dedicated wound care teams, and well-equipped facilities. These resources enable hospitals to provide comprehensive wound care services, including negative pressure wound therapy, to a wide range of patients with various wound types. Hospitals tend to handle patients with more complex and severe wounds compared to other healthcare settings. This includes patients with pressure ulcers, surgical wounds, and other challenging wound types that may require advanced wound care interventions like negative pressure wound therapy. Professionals: Hospitals have a skilled workforce, including wound care specialists, nurses, and surgeons, who are trained in the management of complex wounds. These healthcare professionals have the expertise and experience in utilizing negative pressure wound therapy effectively, ensuring proper application, monitoring, and optimization of the therapy. Hospitals often serve as teaching and research centers, with access to the latest advancements in wound care technologies and treatment modalities. This allows hospitals to stay at the forefront of wound care practices and be early adopters of innovative negative pressure wound therapy products and techniques.
Negative Pressure Wound Therapy Market by Region
The global negative pressure wound therapy market has been geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The North America region has the largest negative pressure wound therapy market size in revenue generation, accounting for around 36.2% market share. The North American market exhibits a high incidence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers. This prevalence is influenced by factors like an aging population, rising rates of diabetes and obesity, and increased life expectancy. Consequently, there is a growing demand for advanced wound management solutions, including Negative Pressure Wound Therapy. According to the Agency for Healthcare Research and Quality, Pressure ulcers affect around 2.5 million U.S. people annually. North America has a well-developed healthcare infrastructure, including advanced hospitals, wound care centers, and specialized wound care clinics. These facilities have the necessary resources, expertise, and reimbursement mechanisms to support the adoption and utilization of negative pressure wound therapy. Healthcare providers in North America prioritize evidence-based practice, relying on clinical research and guidelines to inform their treatment decisions. Negative pressure wound therapy has robust clinical evidence supporting its effectiveness in wound healing. North America is known for its advancements in medical technology. The region witnesses continuous innovation in negative pressure wound therapy devices, dressings, and related accessories. Technological advancements have led to the development of more advanced, user-friendly, and efficient negative pressure wound therapy solutions. These innovations drive the adoption of negative pressure wound therapy in North America.
Negative Pressure Wound Therapy Market Competitive Landscape
The prominent players operating in the global negative pressure wound therapymarket are:
Negative Pressure Wound Therapy Market Strategic Developments
Negative pressure wound therapy is a medical treatment technique that involves the application of negative pressure to a wound site to promote wound healing. It is also known as vacuum-assisted closure (VAC) therapy.
Asia Pacific can be considered the key growth region due to the surge in negative pressure wound therapy industry trends in China, Japan, and the Indian subcontinent.
The prominent players operating in the global negative pressure wound therapy market are Smith & Nephew plc, 3M Company, Cardinal Health, Inc, Alleva Medical Ltd, and Molnlycne Health Care AB.
The global negative pressure wound therapy market growth is estimated to grow at a revenue CAGR of 6.2% during the forecast period from 2023 to 2031.
The estimated size of the global negative pressure wound therapy market in 2031 is US$ 4.55 billion.
*Insights on financial performance are subject to the availability of information in the public domain